Clinical Trial Update: A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function [Phase 2]

View source ↗

Summary

A Phase 2 study tested whether 10 mg vardenafil taken twice daily for six weeks affects bladder function in participants with overactive bladder and detrusor ov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Detrusor Overactivity
• Overactive Bladder

Drugs mentioned

• Vardenafil (vardenafil)

Snippet

Sponsor: Bayer | Conditions: Overactive Bladder, Detrusor Overactivity | Phase 2 | Status: COMPLETED | Results posted: 2009-12-24